Plasma vitamin D is associated with fasting insulin and homeostatic model assessment of insulin resistance in young adult males, but not females, of the Jerusalem Perinatal Study

Public Health Nutrition

Volumn 18, Issue 7, 2015, Pages 1324-1331

  Moore, Amy ^a   Hochner, Hagit ^b   Sitlani, Colleen M ^a   Williams, Michelle A ^c   Hoofnagle, Andrew N ^d   De Boer, Ian H ^a,d   Kestenbaum, Bryan ^a,d   Siscovick, David S ^a,d   Friedlander, Yechiel ^b   Enquobahrie, Daniel A ^a,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e SWEDISH MEDICAL CENTER   (United States)

Author keywords

Cardiometabolic risk; HOMA IR; Vitamin D

Indexed keywords

25 HYDROXYERGOCALCIFEROL; BIOLOGICAL MARKER; CALCIFEDIOL;

ADULT; BLOOD; BODY MASS; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERINSULINISM; HYPERLIPIDEMIAS; INSULIN RESISTANCE; ISRAEL; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D 2; ADULT; BIOMARKERS; BODY MASS INDEX; CALCIFEDIOL; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; HYPERLIPIDEMIAS; INSULIN RESISTANCE; ISRAEL; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; OVERWEIGHT; RISK FACTORS; SEX FACTORS; VITAMIN D DEFICIENCY;

EID: 84926340941     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980014001475     Document Type: Article

References (44)

1. Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80, 6 Suppl., 1678S-16788S.
2. Cranney A, Weiler H, O'Donnell S et al. (2008) Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 88, issue 2, 513S-519S.
3. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357, 266-281.
4. Giovannucci E, Liu Y, Hollis B et al. (2008) 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168, 1174-1180.
5. Zittermann A, Gummert JF & Borgermann J (2009) Vitamin D deficiency and mortality. Curr Opin Clin Nutr Metab Care 12, 634-639.
6. Wang TJ, Pencina MJ, Booth SL et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511.
7. Judd SE & Tangpricha V (2009) Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 338, 40-44.
8. Fiscella K & Franks P (2010) Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 8, 11-18.
9. van Lennep JER, Westerveld HT, Erkelens DW et al. (2002) Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 53, 538-549.
10. Hochner H, Friedlander Y, Calderon-Margalit R et al. (2012) Associations of maternal prepregnancy body mass index and gestational weight gain with adult offspring cardiometabolic risk factors: the Jerusalem Perinatal Family Follow-up Study. Circulation 125, 1381-1389.
11. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96, 1911-1930.
12. Jorde R & Grimnes G (2011) Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 50, 303-312.
13. Kayaniyil S, Vieth R, Harris SB et al. (2011) Association of 25 (OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab 96, 168-175.
14. Zittermann A, Frisch S, Berthold HK et al. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321-1327.
15. 3 for 1 year. J Intern Med 267, 462-472.
16. 3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 137, 495-502.
17. Andersen R, Brot C, Mejborn H et al. (2009) Vitamin D supplementation does not affect serum lipids and lipopro-teins in Pakistani immigrants. Eur J Clin Nutr 63, 1150-1153.
18. 3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26, 19-27.
19. Reid IR, Mason B, Horne A et al. (2002) Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med 112, 343-347.
20. Zemel MB, Shi H, Greer B et al. (2000) Regulation of adiposity by dietary calcium. FASEB J 14, 1132-1138.
21. Kamycheva E, Jorde R, Figenschau Y et al. (2007) Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. J Endocrinol Invest 30, 126-132.
22. Yin X, Sun Q, Zhang X et al. (2012) Serum 25(OH)D is inversely associated with metabolic syndrome risk profile among urban middle-aged Chinese population. Nutr J 11, 68.
23. Delvin EE, Lambert M, Levy E et al. (2010) Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents. J Nutr 140, 987-991.
24. Husemoen LL, Thuesen BH, Fenger M et al. (2012) Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study. Diabetes Care 35, 1695-1700.
25. Choi YJ, Kim HC, Kim HM et al. (2009) Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care 32, 2016-2020.
26. Fraser A, Williams D & Lawlor DA (2010) Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001-2006). PLoS One 5, e13882.
27. Liu E, Meigs JB, Pittas AG et al. (2009) Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 139, 329-334.
28. Del Gobbo LC, Song Y, Dannenbaum DA et al. (2011) Serum 25-hydroxyvitamin D is not associated with insulin resistance or β cell function in Canadian Cree. J Nutr 141, 290-295.
29. Geer EB & Shen W (2009) Gender differences in insulin resistance, body composition, and energy balance. Gend Med 6, Suppl. 1, 60-75.
30. Lipscombe LL & Hux JE (2007) Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 369, 750-756.
31. Collaboration TERF (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375, 2215-2222.
32. Forouhi NG, Luan J, Cooper A et al. (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57, 2619-2625.
33. Mattila C, Knekt P, Mannisto S et al. (2007) Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30, 2569-2570.
34. Belenchia AM, Tosh AK, Hillman LS et al. (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 97, 774-781.
35. Pittas AG, Lau J, Hu FB et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017-2029.
36. Scragg R, Sowers M & Bell C (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27, 2813-2818.
37. Alemzadeh R, Kichler J, Babar G et al. (2008) Hypovitami-nosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57, 183-191.
38. Manco M, Calvani M, Nanni G et al. (2005) Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery. Obes Res 13, 1692-1700.
39. 3 receptor and cal-bindin D28k in human and rat pancreas. Am J Physiol Endocrinol Metab 267, E356-E360.
40. 3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89-90, 121-125.
41. Maestro B, Dávila N, Carranza MC et al. (2003) Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84, 223-230.
42. 3. Cell Biochem Funct 20, 227-232.
43. Zeitz U, Weber K, Soegiarto D et al. (2003) Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17, 509-511.
44. 3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 119, 84-90.